Related Articles
Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugs
Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer
Individualized chemotherapy for colorectal cancer based on the collagen gel droplet-embedded drug sensitivity test
Evaluation of serum iron levels during FOLFOX4 and FOLFIRI therapies
ERCC overexpression associated with a poor response of cT4b colorectal cancer with FOLFOX‑based neoadjuvant concurrent chemoradiation